Olanzapine toxicity in unconjugated hyperbilirubinaemia (Gilbert's syndrome) [4]

British Journal of Psychiatry

Volumn 182, Issue MAR., 2003, Pages 267-

  Martin Escudero J C ^a   Duenas Laita A ^a   Perez Castrillon J L ^a   Herreros Fernandez V ^a  

^a HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; GLUCURONIC ACID; GLUCURONOSYLTRANSFERASE; LORAZEPAM; NEUROLEPTIC AGENT; OLANZAPINE; PHENOTHIAZINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; CASE REPORT; CONJUGATION; CRIGLER NAJJAR SYNDROME; DETOXIFICATION; DRUG METABOLISM; GENE; GILBERT DISEASE; HUMAN; INTERPERSONAL COMMUNICATION; LETTER; LIVER; MALE; MENTAL HEALTH CENTER; MUTATION; MUTISM; POPULATION; PROTEIN POLYMORPHISM; SCHIZOPHRENIA; SPEECH; STIMULATION; SUICIDE ATTEMPT; SYMPTOM; VERBALIZATION;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; GILBERT DISEASE; HUMANS; MALE; PIRENZEPINE; SPEECH DISORDERS;

EID: 17144472340     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.182.3.267     Document Type: Letter

References (5)

1. Burchell, B., Soars, M., Monaghan, G., et al (2000) Drug-mediated toxicity caused by genetic deficiency of UDP-glucuronosyltransferases. Toxicology Letters, 15, 333-340.
2. Cohen, L. G., Fatalo, A., Thompson, B. T., et al (1999) Olanzapine overdose with serum concentrations. Annals of Emergency Medicine, 34, 275-278.
3. Hanel, E. A., Sandmann, M. C., Kranich, M., et al (1998) Neuroleptic malignant syndrome: a case report with recurrence with the use of olanzapine. Arquivos de Neuro-Psiquiatria, 56, 833-837.
4. Mackenzie, P., Miners, J. O. & McKinnon, R. A. (2000) Polymorphisms in UDP glucuronosyltransferase genes: functional consequences and clinical relevance. Clinical Chemistry and Laboratory Medicine. 38, 889-892.
5. Miyaoka,T., Seno, H., Itoga, M., et al (2000) Schizophrenia-associated idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). Journal of Clinical Psychiatry, 61, 868-871.